Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 72
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
     
This article has been cited by
1Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction “R3” Trial): protocol and study design
Muktar H. Aliyu,Usman J. Wudil,Donna J. Ingles,Bryan E. Shepherd,Wu Gong,Baba M. Musa,Hamza Muhammad,Mahmoud U. Sani,Aliyu Abdu,Aisha M. Nalado,Akinfenwa Atanda,Aima A. Ahonkhai,Talat A. Ikizler,Cheryl A. Winkler,Jeffrey B. Kopp,Paul L. Kimmel,C. William Wester
Trials.2019;20(1)
[DOI]
2Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis
Udeme E. Ekrikpo,Andre P. Kengne,Aminu K. Bello,Emmanuel E. Effa,Jean Jacques Noubiap,Babatunde L. Salako,Brian L. Rayner,Giuseppe Remuzzi,Ikechi G. Okpechi,Gianpaolo Reboldi
PLOS ONE.2018;13(4)e0195443
[DOI]
3Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study
Muzamil O. Hassan,Raquel Duarte,Victor O. Mabayoje,Caroline Dickens,Akeem O. Lasisi,Saraladevi Naicker
BMC Nephrology.2020;21(1)e0195443
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal